Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (8): 763-768.DOI: 10.3969/j.issn.1673-8640.2025.08.007
GUO Manman, ZHANG Peng, WANG Runzhi, SHI Long
Received:
2023-12-21
Revised:
2025-01-02
Online:
2025-08-30
Published:
2025-08-28
CLC Number:
GUO Manman, ZHANG Peng, WANG Runzhi, SHI Long. Correlation between the expression of serum lncRNA NEAT1,miR-29c-3p and the disease status,clinical prognosis of epilepsy in children[J]. Laboratory Medicine, 2025, 40(8): 763-768.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.08.007
基因名称 | 上游引物(5'~3') | 下游引物(5'~3') |
---|---|---|
lncRNA NEAT1 | CTTCCTCCCTTTAACTTATCCATTCAC | CTCTTCCTCCACCATTACCAACAATAC |
GAPDH | GCACCGTCAAGGCTGAGAAC | ATGGTGGTGAAGACGCCAGT |
miR-29c-3p | GCCGAGCTTTTTGCGGTCTGGG | CTCAACTGGTGTCGTGGA |
U6 | GCTACGCGCGACCGTGGGCA | CACAGTGGTCTGACACTACGC |
基因名称 | 上游引物(5'~3') | 下游引物(5'~3') |
---|---|---|
lncRNA NEAT1 | CTTCCTCCCTTTAACTTATCCATTCAC | CTCTTCCTCCACCATTACCAACAATAC |
GAPDH | GCACCGTCAAGGCTGAGAAC | ATGGTGGTGAAGACGCCAGT |
miR-29c-3p | GCCGAGCTTTTTGCGGTCTGGG | CTCAACTGGTGTCGTGGA |
U6 | GCTACGCGCGACCGTGGGCA | CACAGTGGTCTGACACTACGC |
组别 | 例数 | lncRNA NEAT1 | miR-29c-3p |
---|---|---|---|
癫痫组 | 102 | 2.51±0.56 | 0.63±0.15 |
正常对照组 | 110 | 1.19±0.30 | 1.03±0.11 |
t值 | 17.649 | -22.252 | |
P值 | <0.001 | <0.001 |
组别 | 例数 | lncRNA NEAT1 | miR-29c-3p |
---|---|---|---|
癫痫组 | 102 | 2.51±0.56 | 0.63±0.15 |
正常对照组 | 110 | 1.19±0.30 | 1.03±0.11 |
t值 | 17.649 | -22.252 | |
P值 | <0.001 | <0.001 |
组别 | 例数 | lncRNA NEAT1 | miR-29c-3p |
---|---|---|---|
轻度组 | 50 | 2.23±0.51 | 0.73±0.09 |
中度组 | 24 | 2.59±0.47* | 0.61±0.11* |
重度组 | 28 | 2.93±0.41*# | 0.47±0.13*# |
F值 | 19.946 | 53.651 | |
P值 | <0.001 | <0.001 |
组别 | 例数 | lncRNA NEAT1 | miR-29c-3p |
---|---|---|---|
轻度组 | 50 | 2.23±0.51 | 0.73±0.09 |
中度组 | 24 | 2.59±0.47* | 0.61±0.11* |
重度组 | 28 | 2.93±0.41*# | 0.47±0.13*# |
F值 | 19.946 | 53.651 | |
P值 | <0.001 | <0.001 |
项目 | 例数 | 年龄/岁 | 性别 | BMI/ (kg·m-2) | 病程/年 | 发热/ [例(%)] | ||
---|---|---|---|---|---|---|---|---|
男/[例(%)] | 女/[例(%)] | |||||||
预后不良组 | 28 | 7.69±2.33 | 16(57.14) | 12(42.86) | 22.64±2.36 | 3.46±0.51 | 20(71.43) | |
预后良好组 | 74 | 7.43±2.16 | 39(52.70) | 35(47.30) | 22.15±2.69 | 3.31±0.43 | 51(68.92) | |
统计值 | 0.531 | 0.161 | 0.862 | 1.492 | 0.060 | |||
P值 | 0.597 | 0.688 | 0.391 | 0.139 | 0.806 | |||
项目 | 发作后治疗 | 脑脊液检测 | lncRNA NEAT1 | miR-29c-3p | ||||
单药/ [例(%)] | 2种药/ [例(%)] | 3种药及以上/ [例(%)] | 异常/ [例(%)] | 正常/ [例(%)] | ||||
预后不良组 | 16(57.14) | 7(25.00) | 5(17.86) | 8(28.57) | 20(71.43) | 3.01±0.43 | 0.43±0.12 | |
预后良好组 | 45(60.81) | 18(24.32) | 11(14.87) | 19(25.68) | 55(74.32) | 2.32±0.41 | 0.71±0.18 | |
统计值 | 0.165 | 0.088 | 7.485 | 7.605 | ||||
P值 | 0.921 | 0.767 | <0.001 | <0.001 |
项目 | 例数 | 年龄/岁 | 性别 | BMI/ (kg·m-2) | 病程/年 | 发热/ [例(%)] | ||
---|---|---|---|---|---|---|---|---|
男/[例(%)] | 女/[例(%)] | |||||||
预后不良组 | 28 | 7.69±2.33 | 16(57.14) | 12(42.86) | 22.64±2.36 | 3.46±0.51 | 20(71.43) | |
预后良好组 | 74 | 7.43±2.16 | 39(52.70) | 35(47.30) | 22.15±2.69 | 3.31±0.43 | 51(68.92) | |
统计值 | 0.531 | 0.161 | 0.862 | 1.492 | 0.060 | |||
P值 | 0.597 | 0.688 | 0.391 | 0.139 | 0.806 | |||
项目 | 发作后治疗 | 脑脊液检测 | lncRNA NEAT1 | miR-29c-3p | ||||
单药/ [例(%)] | 2种药/ [例(%)] | 3种药及以上/ [例(%)] | 异常/ [例(%)] | 正常/ [例(%)] | ||||
预后不良组 | 16(57.14) | 7(25.00) | 5(17.86) | 8(28.57) | 20(71.43) | 3.01±0.43 | 0.43±0.12 | |
预后良好组 | 45(60.81) | 18(24.32) | 11(14.87) | 19(25.68) | 55(74.32) | 2.32±0.41 | 0.71±0.18 | |
统计值 | 0.165 | 0.088 | 7.485 | 7.605 | ||||
P值 | 0.921 | 0.767 | <0.001 | <0.001 |
项目 | AUC(95%CI①) | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|
lncRNA NEAT1 | 0.849(0.765~0.912) | 2.52 | 89.29 | 66.22 | 0.555 |
miR-29c-3p | 0.867(0.785~0.926) | 0.49 | 78.57 | 83.78 | 0.624 |
联合检测 | 0.937(0.871~0.975) | 0.42 | 82.11 | 93.23 | 0.753 |
项目 | AUC(95%CI①) | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|
lncRNA NEAT1 | 0.849(0.765~0.912) | 2.52 | 89.29 | 66.22 | 0.555 |
miR-29c-3p | 0.867(0.785~0.926) | 0.49 | 78.57 | 83.78 | 0.624 |
联合检测 | 0.937(0.871~0.975) | 0.42 | 82.11 | 93.23 | 0.753 |
[1] | 杨萍, 李愉. 生酮饮食对癫痫患儿癫痫发作、脑电图及神经行为发育的影响[J]. 当代医药论丛, 2022, 20(18):103-105. |
[2] | 柴长凤, 胡瑞宏, 侯晓军. 血清学标志物对癫痫发作诊断作用的研究进展[J]. 临床神经病学杂志, 2020, 33(5):396-400. |
[3] | 陈升东, 孔令明, 何明骏, 等. 癫痫患者人格改变与外周血lncRNA表达水平的关系[J]. 中华行为医学与脑科学杂志, 2021, 30(3):238-243. |
[4] |
屈会霞, 袁小锋, 屈昕. 长链非编码RNA核富含丰富的转录本1对癫痫模型海马神经元凋亡的影响和作用机制[J]. 中国儿童保健杂志, 2021, 29(11):1193-1197.
DOI |
[5] | 高岩, 张春阳, 邵国, 等. 血清外泌体miRNA在癫痫发作中潜在作用的研究[J]. 临床神经外科杂志, 2022, 19(5):515-520. |
[6] | LIU S, FAN M, MA M D, et al. Long non-coding RNAs:potential therapeutic targets for epilepsy[J]. Front Neurosci, 2022,16:986874. |
[7] | 中国抗癫痫协会. 临床诊疗指南·癫痫病分册(2015修订版)[M]. 北京: 人民卫生出版社, 2015. |
[8] | SIDHARTH, SHARMA S, JAIN P, et al. Status Epilepticus in Pediatric patients Severity Score(STEPSS):a clinical score to predict the outcome of status epilepticus in children-a prospective cohort study[J]. Seizure, 2019,71:328-332. |
[9] | 李婧萱, 时黛, 伍国锋. 环磷酸腺苷反应元件结合蛋白调控耐药性癫痫大鼠海马内脑源性神经营养因子的表达[J]. 中国组织工程研究, 2023, 27(35):5659-5664. |
[10] | 韩玉娟, 邓劼. 癫痫持续状态患儿血清载脂蛋白A2免疫球蛋白A和腺苷脱氨酶的表达及意义[J]. 中国实用神经疾病杂志, 2022, 25(5):603-608. |
[11] | SUERI C, GASPARINI S, BALESTRINI S, et al. Diagnostic biomarkers of epilepsy[J]. Curr Pharm Biotechnol, 2018, 19(6):440-450. |
[12] | FANG K, LI H R, CHEN X X, et al. Corrigendum:quercetin alleviates LPS-induced depression-like behavior in rats via regulating BDNF-related imbalance of copine 6 and TREM1/2 in the hippocampus and PFC[J]. Front Pharmacol, 2020,11:518. |
[13] |
KUMAR P, LIM A, HAZIRAH S N, et al. Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling[J]. Nat Neurosci, 2022, 25(7):956-966.
DOI PMID |
[14] | BARRY G, BRIGGS J A, HWANG D W, et al. The long non-coding RNA NEAT1 is responsive to neuronal activity and is associated with hyperexcitability states[J]. Sci Rep, 2017,7:40127. |
[15] |
WAN Y, YANG Z Q. LncRNA NEAT1 affects inflammatory response by targeting miR-129-5p and regulating Notch signaling pathway in epilepsy[J]. Cell Cycle, 2020, 19(4):419-431.
DOI PMID |
[16] |
MA Y. The challenge of microRNA as a biomarker of epilepsy[J]. Curr Neuropharmacol, 2018, 16(1):37-42.
DOI PMID |
[17] | ZHANG M, YANG H, CHEN Z, et al. Long noncoding RNA X-inactive-specific transcript promotes the secretion of inflammatory cytokines in LPS stimulated astrocyte cell via sponging miR-29c-3p and regulating nuclear factor of activated T cell 5 expression[J]. Front Endocrinol(Lausanne), 2021,12:573143. |
[18] |
COSTARD L S, NEUBERT V, VENØ M T, et al. Electrical stimulation of the ventral hippocampal commissure delays experimental epilepsy and is associated with altered microRNA expression[J]. Brain Stimul, 2019, 12(6):1390-1401.
DOI PMID |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||